With devising a kind of advanced whole-genome single-cell sequencing, we use single-cell exome sequencing to characterize the single-nucleotide mutations and tumor evolution of two tumors: a JAK2-negative myeloproliferative neoplasm and a clear cell renal cell carcinoma.